Effect of BMI on toxicities and survival among adolescents and young adults treated on DFCI Consortium ALL trials

Adolescent and young adults (AYAs) with acute lymphoblastic leukemia (ALL) treated with asparaginase-containing pediatric regimens are commonly overweight or obese. We studied the association of body mass index (BMI) on outcomes of 388 AYAs aged 15 to 50 years treated on Dana-Farber Cancer Institute...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimony, Shai, Flamand, Yael, Valtis, Yannis K., Place, Andrew E., Silverman, Lewis B., Vrooman, Lynda M., Brunner, Andrew M., Sallan, Stephen E., Stone, Richard M., Wadleigh, Martha, Neuberg, Donna S., DeAngelo, Daniel J., Luskin, Marlise R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Clinical Trials and Observations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500474/
https://www.ncbi.nlm.nih.gov/pubmed/37432068
http://dx.doi.org/10.1182/bloodadvances.2023009976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500474/
https://www.ncbi.nlm.nih.gov/pubmed/37432068
http://dx.doi.org/10.1182/bloodadvances.2023009976

Ejemplares similares